1-2 of 2
Antonio Jimenez Jimenez
Close
Sort by
Journal Articles

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Monzr M. Al Malki, Steven M Devine, Bronwen E. Shaw, Larisa Broglie, Muna Qayed, Sung W. Choi, Stephen R. Spellman, Craig Malmberg, Eric Ndifon, Brent Logan, Jeffery Auletta, Heather E Stefanski, Janelle A. Olson, Antonio Jimenez Jimenez
Journal: Blood
Blood (2022) 140 (Supplement 1): 7591–7593.
https://doi.org/10.1182/blood-2022-162581
Published: 2022
Journal Articles

Bridging the Gap in Access to Transplant for Underserved Minority Patients Using Mismatched Unrelated Donors and Post-Transplant Cyclophosphamide: A National Marrow Donor Program/be the Match (NMDP/BTM) Initiative

Bronwen E. Shaw, PhD MRCP, FRCPath, Antonio Jimenez-Jimenez, MD MS, Linda J. Burns, MD, Brent Logan, PhD, Farhad Khimani, MD, Brian C. Shaffer, MD, Nirav N. Shah, MD, Alisha Mussetter, BS, ACRP-CP, Xiao-Ying Tang, MPH, John M McCarty, MD, Asif Alavi, MD, Nosha Farhadfar, MD, Katarzyna Jamieson, MD, Nancy M. Hardy, MD, Hannah Choe, MD, Richard F. Ambinder, MD, Claudio Anasetti, MD, Miguel-Angel Perales, MD, Alan Howard, PhD, Krishna V Komanduri, MD, Leo Luznik, MD, Maxim Norkin, MD PhD, Joseph Pidala, MD, Voravit Ratanatharathorn, MD, Dennis L. Confer, MD, Steven M Devine, MD, Mary M. Horowitz, MD MS, Javier Bolanos-Meade, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-137677
Published: 2020